Since the work of McAlpine and Compston [1] , the natural history of multiple sclerosis (MS) has been addressed by many studies, and is now well delineated (see [2] for a review). There are still some nests for deeper investigations and this is precisely the quest of Tremlett and co-workers regarding secondary progressive MS (SPMS) [3] . They have selected 2484 cases with an exacerbating-remitting onset of MS from the British Columbia MS database with a minimum disease duration of 15 years, a minimum follow-up of 5 years and virtually no administration of currently acknowledged disease-modifying treatments at the time of the survey. At that time, 1445 patients had already converted to SPMS (58.2%). This is the largest series of its kind. The Canadian authors found that the median time from an exacerbating-remitting onset of MS to conversion to secondary progression could be estimated using the Kaplan-Meier technique to be 18.9 years (95% confidence interval (CI) 18.2-19.7), a result which perfectly matches the 19.1 years (95% CI 17.1-21.1) observed in the Lyon MS cohort of 1562 patients with an exacerbating-remitting onset of MS [2, 4] . Both studies report a fairly linear rate of conversion to secondary progression, a fact first demonstrated by McAlpine and Compston in [1] : 'There is a fairly constant rate of change from a remitting to a progressive course, and a gradual rise in the total percentage of progressive cases as the disease advances'. This rate of conversion is therefore about 2.5% patients per year converting to secondary progression. The Canadian work also shows that the estimated median age at conversion to secondary progression is 49.0 years (95% CI 48.3-49.7) for the whole population of patients with an exacerbating-remitting onset of MS. In this population of patients, it is also observed that the clinical predictors associated with a shorter time to secondary progression are mainly an older age at onset of MS and, to some extent, male gender, but not initial symptoms of the disease. Taken together, these results fit well with most of the available literature [2] .
The Canadian group provides some novel information when focusing on the time from onset of SPMS to reaching Expanded Disability Status Scale (EDSS) 8: this time interval is longer when, at onset of SPMS, disease duration has been longer, age older and EDSS lower. This seems paradoxical. Indeed, it is usually stated that 'the older the age at onset, the shorter the time to reach disability outcomes'. Here, however, it is not the age at onset of MS but the age at onset of secondary progression that is considered. A first explanation of this apparent paradox is that it reflects the slope of accumulation of irreversible disability in MS, which is somewhat linear and stable for each individual but very different among individuals [5, 6] . A second explanation is technical. The proportion of censored patients, i.e. the proportion of patients who had not yet reached EDSS 8 at the time of the survey in the Canadian study, was high, but also differential, increasing progressively from 64.5% for patients with age at onset of secondary progression under 30 years to 92.8% for patients over 50 years [3; Figure 2 ]. It is known that the higher the proportion of "right-censored" patients, the higher the over-estimate in the results provided by the Kaplan-Meier technique [2; Figure 4 .3]. Such explanations definitely need to be confirmed.
Much like some other papers published lately [7] , the Canadian paper tends to put forward the onset of secondary progression as an outcome of choice in the study of the course and prognosis of MS. As the authors emphasize, it can often be indistinct from prospective follow-up and so is typically assigned retrospectively on clinical grounds. There is a fairly good agreement between observers when assessing the date of secondary progression at a given time [8, 9] . Nevertheless, such a choice may be disputed. In essence, it is appropriate only for the cases with an exacerbating-remitting onset of the disease, excluding those with a primary onset. In our experience with the longitudinal follow-up of MS patients, the need to reconsider the date, or even the status per se, of secondary conversion is not rare. The assessment of onset of secondary progression is based only on a somewhat subjective impression of the examiner and the patient with no objective quantitative support. In contrast, choosing irreversible disability milestones as an outcome of choice in MS offers several advantages over conversion to secondary progression. It relies upon objective, quantitative (ordinal at least) evaluation. It is easy to assess in retrospect during the longitudinal follow-up of MS patients, as the condition disability assessments are made at reasonable intervals and the disability scoring is based upon objective ambulation abilities [10] [11] [12] [13] . The inter-examiner consistency is good [9] . This approach provides several levels of the outcome measures, instead of one. This allows for an internal coherence evaluation by analyzing the sequence of events in a logical order. In contrast, attempting to study the relationship between onset of secondary progression and the reaching of disability milestones is often awkward. Convincing evidence is provided by Tremlett, et al. [3] . As the onset of secondary progression usually occurs within the 4-7 range of the EDSS scale, i.e. either before or after one or the other of these EDSS steps depending on the individual patient, it has not been possible for the authors to produce pertinent results regarding the transition from onset of secondary progression to EDSS 6. Only the transition to EDSS 8, a step usually reached after the onset of secondary progression, but also very late in the course of the disease, has been liable to appropriate analysis. Last, and not surprisingly, the clinical predictors which influence the time from onset of MS to secondary progression are similar to those that influence the time from onset of MS to disability milestones. In other words, by comparison with disability milestones, selecting onset of secondary progression as the main outcome in the course of MS affords nothing more, introduces some imprecision, reduces the analysis to a single step and is not easily handled in combination with disability milestones.
A major issue about the British Columbian study on natural history of SPMS concerns the incompleteness of data on disability. In this work, analyses dismissed the cases which had reached EDSS scores of 6 or 8 before the first visit at the clinic, or before the onset of SPMS. This restriction concerned 46.8% of the patients for EDSS 6 and 12% for EDSS 8 analyses. This is why the authors eventually abandoned analyzing EDSS 6 as it was not a worthy outcome in their series and concentrated on EDSS 8. This raises a larger issue about the entire British Columbia cohort and not just the SPMS cases. Indeed, the cases who have reached the EDSS scores of 6 or 8 before the first visit at the clinic make up a group of presumably more severe cases than those who reached these disability milestones after this visit. Excluding them may bias the results to the right, i.e. over-estimating the time to and age at reaching disability milestones. Such a bias may be non-trivial. For instance, the 25% percentile for age at reaching EDSS 8 in the SPMS patients was estimated by the Canadian authors [3; Table 3 ] at 70.1 years, a figure hardly compatible with a normal life expectancy.
Another important point to consider is the concept of reaching irreversible disability milestones. Disability has been defined as irreversible when a given score persists over six months at least, excluding transient worsening related to relapses [10] . In essence, when a given score of irreversible disability has been assigned to a given patient, all of the scores of disability assessed afterwards for this patient during the subsequent course of the disease are either equal to or higher than that score. When the focus is placed on the patient's ability to walk, scores such as EDSS 4, 6 and 7 can easily be assessed retrospectively. This way of working allows a better estimate of the "true" date when a given score has been reached for the first time irreversibly during the course of the disease for a given individual. Obviously, this date does not necessarily coincide with the first neurological assessment exhibiting this score during the follow-up and registered in the database. In the British Columbian study, the approach for disability analysis has been different. The date of reaching a disability milestone has been assigned from the prospective follow-up only and coincided with the first disability assessment showing it, provided that the subsequent assessed disability scores, when available, were equal to or higher than it.
In conclusion, there are several peculiarities in the British Columbia series which may concur to over-estimate the time to and the age at reaching disease outcomes. This is not true for the onset of secondary progression, as this criterion has been assessed retrospectively for all relevant patients and, not surprisingly, the Canadian results in this domain are in close agreement with those currently available in the literature. In contrast, this is very likely the case for the disability milestones leading to results clearly diverging from the literature [2] . Considering the current evidence, it may be presumed that the disability accumulation in MS is not as slow as recently stated by the Canadian group [14] .
All of the studies on the natural history of MS have their limitations. However, they have become unique as we have entered the therapeutic era of MS. In order to know the full story on the natural history of MS, we have to follow up the patients of such series until the end of their disease. This will provide us with complete and true data on the selected outcomes without missing data issues leading to erroneous estimates. This is a long route, however, but it is our duty and responsibility to take it.
